Futura Medical plc (LON:FUM – Get Free Report) shares dropped 12.4% on Friday. The company traded as low as GBX 0.18 and last traded at GBX 0.18. Approximately 31,148,195 shares changed hands during mid-day trading, an increase of 195% from the average session volume of 10,547,822 shares. The stock had previously closed at GBX 0.21.
Futura Medical Stock Down 12.4%
The stock has a fifty day moving average of GBX 0.29 and a two-hundred day moving average of GBX 0.57. The stock has a market cap of £2.73 million, a price-to-earnings ratio of -0.23 and a beta of 0.02.
Futura Medical (LON:FUM – Get Free Report) last released its quarterly earnings data on Tuesday, September 1st. The company reported GBX (0.20) earnings per share (EPS) for the quarter. Futura Medical had a negative return on equity of 152.42% and a negative net margin of 158.21%. Equities research analysts anticipate that Futura Medical plc will post 2.85 EPS for the current fiscal year.
About Futura Medical
Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.
Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.
See Also
- Five stocks we like better than Futura Medical
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for Futura Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical and related companies with MarketBeat.com's FREE daily email newsletter.
